ENGAGE run · 2ce34972e844

```json [ { "post_index": 2, "cluster_ids": [5, 9], "claim": "Insurance companies subcontract denial decisions to overseas PE-owned firms", "argument_type": "empirical_claim", "stance": "challenges_status_quo", "hyde_excerpt": "Prior authorization denials have increasingly been outsourced to third-party vendors owned by private equity firms with minimal domestic regulator

```json [ { "post_index": 3, "matched_article_id": 509, "match_confidence": 87, "match_reason": "The tweet argues that peptides lack quality standards, outcome tracking, and a data infrastructure layer — precisely the market gap the article analyzes through the lens of 8% endotoxin contamination in gray-market peptides, the absence of COA aggregation and supply chain traceability

The gray market data makes that infrastructure case pretty well on its own: 8% endotoxin contamination in independently tested RUO peptide samples, which I detailed alongside the broader regulatory picture at https://www.onhealthcare.tech/p/the-category-2-peptide-unwind-how?utm_source=x&utm_medium=reply&utm_content=2050606241836105914&utm_campaign=the-category-2-peptide-unwind-how, and that number

8% endotoxin contamination in independently tested research-use-only peptide samples is the number that keeps getting buried in these conversations. That figure came out of lot-level testing, and it maps directly onto what you're showing here. No cleanroom, no validated sterilization cycle, no certificate of analysis that means anything. The cGMP problem is real, but the specific failure mode is

The framing of "replace" is where I'd push back, the data points somewhere more specific. PCPs over-refer defensively, not because they lack the clinical chops, and dropping an AI layer plus asynchronous specialist review into that workflow could absorb 20-30% of referral volume without the physician ever leaving the loop. The Ontario eConsult program ran nearly 100,000 cases at a two-day average

The validation bottleneck point is real, I've been tracking this exact dynamic. But the volume ceiling is already being pushed by AI in ways that matter for compensation: Aidoc and Viz.ai are pulling incidental findings and prioritizing worklists, which means radiologists are spending less time on the easy reads and more time on the complex ones that actually drive RVUs upward. And the ceiling yo

The accuracy number is the least interesting part of this study, honestly. 67% correct on 76 ER cases is a reasonable headline but it tells you nothing about what happens when the AI is wrong and a physician deferred to it, or when the AI was right and a physician overrode it. Both of those scenarios have liability written all over them. The deeper problem is that accuracy in a controlled study

```json [] ```

[]

```json [ {"post_index": 0, "prediction": "reject", "confidence": 95, "reason": "Sports content unrelated to healthcare"}, {"post_index": 1, "prediction": "reject", "confidence": 90, "reason": "Food/nutrition claim without healthcare context or analysis"}, {"post_index": 2, "prediction": "reje

```json [ { "category": "ai_safety_cybersecurity_incident_tangential", "summary": "Posts about AI safety vulnerabilities, security breaches, or hacking incidents that lack healthcare systems context or application.", "exclusion_rule": "Exclude posts that report AI model security incide